|
Volumn 126, Issue 5, 2010, Pages
|
Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DANAPAROID;
DOUBLE STRANDED DNA ANTIBODY;
LOW MOLECULAR WEIGHT HEPARIN;
METHYLPREDNISOLONE;
RECOMBINANT THROMBOMODULIN;
RECOMODULIN;
UNCLASSIFIED DRUG;
VON WILLEBRAND FACTOR CLEAVING PROTEINASE;
ADULT;
BLOOD CLOTTING DISORDER;
CASE REPORT;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
COMORBIDITY;
DISEASE COURSE;
DRUG EFFICACY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
INTERSTITIAL PNEUMONIA;
LETTER;
PATHOGENESIS;
PRIORITY JOURNAL;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOGENESIS;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
FEMALE;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MIDDLE AGED;
PURPURA, THROMBOTIC THROMBOCYTOPENIC;
RECOMBINANT PROTEINS;
THROMBOMODULIN;
|
EID: 78149280175
PISSN: 00493848
EISSN: None
Source Type: Journal
DOI: 10.1016/j.thromres.2010.06.024 Document Type: Letter |
Times cited : (11)
|
References (7)
|